Recent Journal Updates

DiabetologiaJun 6, 2026

Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages

Clinical Context

We think this has broad domain relevance to Delta-Delta Ratio (ΔAG/ΔHCO₃).

DiabetologiaJun 6, 2026

Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial

Clinical Context

We think this has broad domain relevance to Delta-Delta Ratio (ΔAG/ΔHCO₃).

Intensive Care MedicineJun 2, 2026

Nutrition support in the ICU: current evidence and evolving standards

Clinical Context

We think this has broad domain relevance to Delta-Delta Ratio (ΔAG/ΔHCO₃).

Delta-Delta Ratio

Delta-Delta Matrix

Mixed Disorder Interpretation

Substrate Analysis

Anion Gap (AG)

Bicarbonate (HCO₃)

Mixed Solver

Enter AG and HCO₃ to resolve complex mixed acid-base patterns.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

What is the Delta-Delta Ratio?

The delta-delta ratio (ΔAG/ΔHCO₃) is a calculated value that helps identify mixed acid-base disorders in patients with high anion gap metabolic acidosis (HAGMA). It compares the change in anion gap (ΔAG = measured AG - normal AG) to the change in bicarbonate (ΔHCO₃ = normal HCO₃ - measured HCO₃). In a pure HAGMA (e.g., isolated lactic acidosis or DKA without complications), each 1 mEq/L increase in AG should be matched by a 1 mEq/L decrease in HCO₃ (ratio ≈ 1). If the ratio is significantly lower or higher, a second acid-base disorder is present: a ratio <1 suggests coexisting normal anion gap metabolic acidosis (NAGMA, bicarbonate loss from another source), while a ratio >1 suggests coexisting metabolic alkalosis (bicarbonate retention). The delta-delta ratio is especially useful in critically ill patients who often have multiple simultaneous acid-base disturbances.

Primary Clinical Indications

Identification of mixed acid-base disorders – Detects coexisting metabolic alkalosis or NAGMA in patients with HAGMA (common in DKA with vomiting, DKA with diarrhea, lactic acidosis in ICU patients on diuretics)

Evaluation of unexplained HCO₃ level – If HCO₃ is not as low as expected for the degree of AG elevation, suspect metabolic alkalosis; if HCO₃ is lower than expected, suspect NAGMA

Assessment of DKA patients – In DKA, delta-delta ratio should be ~1.0-1.2 (pure HAGMA). If ratio >1.2-1.5, suspect vomiting (metabolic alkalosis); if ratio <0.8, suspect diarrhea or saline-induced hyperchloremia (NAGMA)

ICU acid-base monitoring – Critically ill patients often have multiple disorders (e.g., lactic acidosis + dilutional acidosis + metabolic alkalosis from NG suction). Delta-delta helps identify components

Evaluation of renal failure patients – In uremic acidosis, delta-delta ratio may be <1 due to hyperchloremia (NAGMA component) from renal tubular dysfunction

Diagnosis of mixed disorders in salicylate toxicity – Salicylates cause both respiratory alkalosis (direct CNS stimulation) and HAGMA; delta-delta may be variable

Monitoring response to therapy – As HAGMA resolves, delta-delta should normalize; persistent abnormality suggests ongoing mixed disorder

Contraindications / Limitations

Assumes 1:1 stoichiometry – The formula assumes that each 1 mEq/L increase in unmeasured anions consumes exactly 1 mEq/L of HCO₃. This is true for lactic acidosis and ketoacidosis but varies for other organic acids (e.g., methanol, ethylene glycol, uremia)

Uncertainty in normal values – Requires assuming a "normal" AG (typically 10-12 mEq/L) and "normal" HCO₃ (24 mEq/L). Different baselines change the ratio

Albumin effect – Hypoalbuminemia lowers baseline AG; failure to use corrected AG biases delta-delta ratio (corrected AG should be used)

Volume of distribution differences – Unmeasured anions and HCO₃ have different volumes of distribution, making the 1:1 assumption an approximation

Not validated in all clinical scenarios – Most validation studies are in DKA and lactic acidosis; performance in uremia, toxic alcohols, and other disorders is less certain

Requires accurate acid-base diagnosis first – Delta-delta is only meaningful if HAGMA is confirmed; do not use if AG is normal

May be misleading in mixed respiratory-metabolic disorders – Respiratory alkalosis or acidosis can shift HCO₃ independently, complicating interpretation

Poor sensitivity for mild mixed disorders – Small deviations from 1:1 may be within measurement error; only large ratio deviations (>1.5 or <0.6) are clinically significant

Delta-Delta Ratio in Different Clinical Scenarios

Ratio Range	Interpretation	Common Clinical Examples	Mechanism
<0.4	HAGMA + severe NAGMA (or dilutional acidosis)	DKA + diarrhea; DKA + saline hydration (hyperchloremia); Lactic acidosis + renal tubular acidosis; Uremic acidosis with hyperchloremia	Bicarbonate loss from two separate sources (organic acids + GI/renal HCO₃ loss) → ΔHCO₃ much larger than ΔAG
0.4-0.8	HAGMA + NAGMA (common in treated DKA)	DKA after 4-6 hours of IV fluids (saline-induced hyperchloremia); Mild lactic acidosis + diarrhea; Uremic acidosis (uremic anions + tubular dysfunction)	Moderate bicarbonate loss from both sources; ratio less than 1 but not extreme
0.8-1.2	Pure HAGMA (or HAGMA with minimal NAGMA/alkalosis)	Isolated lactic acidosis (sepsis, ischemia); Uncomplicated DKA (before fluid therapy); Methanol poisoning (early); Ethylene glycol poisoning (early)	Each 1 mEq/L AG increase corresponds to ~1 mEq/L HCO₃ decrease; no additional bicarbonate loss or retention
1.2-2.0	HAGMA + mild-moderate metabolic alkalosis	DKA + vomiting; Lactic acidosis + NG suction; Lactic acidosis + thiazide diuretics; DKA + diuretics	Bicarbonate retention (alkalosis) offsets some of the expected HCO₃ drop, so ΔHCO₃ is smaller than ΔAG
>2.0	HAGMA + severe metabolic alkalosis (or high baseline HCO₃)	DKA with severe vomiting; Lactic acidosis with chronic respiratory acidosis (COPD, high baseline HCO₃); Post-dialysis alkalosis + lactic acidosis	HCO₃ is normal or elevated despite HAGMA, indicating significant alkalosis (either metabolic or respiratory compensation)

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Anion Gap Calculator, Calculated Osmolality, Winter's Formula or the Corrected Bicarbonate to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Pathology Tools

Anion Gap

Fractional Excretion of Urea

Fractional Excretion of Sodium

Corrected Sodium

Calculated Serum Osmolality

Pathology Calculators Internal Medicine Calculators Emergency Medicine Calculators

Have feedback about this calculator?Let us know.

Recent Journal Updates

DiabetologiaJun 6, 2026

Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages

Clinical Context

We think this has broad domain relevance to Delta-Delta Ratio (ΔAG/ΔHCO₃).

DiabetologiaJun 6, 2026

Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial

Clinical Context

We think this has broad domain relevance to Delta-Delta Ratio (ΔAG/ΔHCO₃).

Intensive Care MedicineJun 2, 2026

Nutrition support in the ICU: current evidence and evolving standards

Clinical Context

We think this has broad domain relevance to Delta-Delta Ratio (ΔAG/ΔHCO₃).

Delta-Delta Ratio

Delta-Delta Matrix

Mixed Disorder Interpretation

Substrate Analysis

Anion Gap (AG)

Bicarbonate (HCO₃)

Mixed Solver

Enter AG and HCO₃ to resolve complex mixed acid-base patterns.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

What is the Delta-Delta Ratio?

Primary Clinical Indications

Evaluation of unexplained HCO₃ level – If HCO₃ is not as low as expected for the degree of AG elevation, suspect metabolic alkalosis; if HCO₃ is lower than expected, suspect NAGMA

Evaluation of renal failure patients – In uremic acidosis, delta-delta ratio may be <1 due to hyperchloremia (NAGMA component) from renal tubular dysfunction

Diagnosis of mixed disorders in salicylate toxicity – Salicylates cause both respiratory alkalosis (direct CNS stimulation) and HAGMA; delta-delta may be variable

Monitoring response to therapy – As HAGMA resolves, delta-delta should normalize; persistent abnormality suggests ongoing mixed disorder

Contraindications / Limitations

Uncertainty in normal values – Requires assuming a "normal" AG (typically 10-12 mEq/L) and "normal" HCO₃ (24 mEq/L). Different baselines change the ratio

Albumin effect – Hypoalbuminemia lowers baseline AG; failure to use corrected AG biases delta-delta ratio (corrected AG should be used)

Volume of distribution differences – Unmeasured anions and HCO₃ have different volumes of distribution, making the 1:1 assumption an approximation

Not validated in all clinical scenarios – Most validation studies are in DKA and lactic acidosis; performance in uremia, toxic alcohols, and other disorders is less certain

Requires accurate acid-base diagnosis first – Delta-delta is only meaningful if HAGMA is confirmed; do not use if AG is normal

May be misleading in mixed respiratory-metabolic disorders – Respiratory alkalosis or acidosis can shift HCO₃ independently, complicating interpretation

Poor sensitivity for mild mixed disorders – Small deviations from 1:1 may be within measurement error; only large ratio deviations (>1.5 or <0.6) are clinically significant

Delta-Delta Ratio in Different Clinical Scenarios

Ratio Range	Interpretation	Common Clinical Examples	Mechanism
<0.4	HAGMA + severe NAGMA (or dilutional acidosis)	DKA + diarrhea; DKA + saline hydration (hyperchloremia); Lactic acidosis + renal tubular acidosis; Uremic acidosis with hyperchloremia	Bicarbonate loss from two separate sources (organic acids + GI/renal HCO₃ loss) → ΔHCO₃ much larger than ΔAG
0.4-0.8	HAGMA + NAGMA (common in treated DKA)	DKA after 4-6 hours of IV fluids (saline-induced hyperchloremia); Mild lactic acidosis + diarrhea; Uremic acidosis (uremic anions + tubular dysfunction)	Moderate bicarbonate loss from both sources; ratio less than 1 but not extreme
0.8-1.2	Pure HAGMA (or HAGMA with minimal NAGMA/alkalosis)	Isolated lactic acidosis (sepsis, ischemia); Uncomplicated DKA (before fluid therapy); Methanol poisoning (early); Ethylene glycol poisoning (early)	Each 1 mEq/L AG increase corresponds to ~1 mEq/L HCO₃ decrease; no additional bicarbonate loss or retention
1.2-2.0	HAGMA + mild-moderate metabolic alkalosis	DKA + vomiting; Lactic acidosis + NG suction; Lactic acidosis + thiazide diuretics; DKA + diuretics	Bicarbonate retention (alkalosis) offsets some of the expected HCO₃ drop, so ΔHCO₃ is smaller than ΔAG
>2.0	HAGMA + severe metabolic alkalosis (or high baseline HCO₃)	DKA with severe vomiting; Lactic acidosis with chronic respiratory acidosis (COPD, high baseline HCO₃); Post-dialysis alkalosis + lactic acidosis	HCO₃ is normal or elevated despite HAGMA, indicating significant alkalosis (either metabolic or respiratory compensation)

Related Scores in Practice

Last Comprehensive Review: 2026

Related Pathology Tools

Anion Gap

Fractional Excretion of Urea

Fractional Excretion of Sodium

Corrected Sodium

Calculated Serum Osmolality

Pathology Calculators Internal Medicine Calculators Emergency Medicine Calculators

Have feedback about this calculator?Let us know.